Nasdaq: KYNB

Kyntra Bio, Inc. (KYNB)

Kyntra Bio, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker KYNB. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
KYNB
Exchange
Nasdaq
SEC CIK
921299
Official filings
SEC EDGAR

Research KYNB

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Kyntra Bio, Inc.'s stock ticker?

Kyntra Bio, Inc. trades under the ticker symbol KYNB on Nasdaq. Its SEC Central Index Key (CIK) is 921299.

Where can I read Kyntra Bio, Inc.'s SEC filings?

The KYNB SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Kyntra Bio, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze KYNB's financial statements?

The KYNB Financials page shows Kyntra Bio, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does KYNB compare with its peers and the market?

The KYNB Peer Comparison page lines Kyntra Bio, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.